美国食品药品监督管理局的一个顾问小组上周给予Grail的Galleri血液检测一项里程碑式的胜利，称这种早期癌症检测的潜在益处大于风险，使其离获批更近一步。
An advisory panel to the US Food and Drug Administration handed Grail's Galleri blood test a milestone win last week, saying the early cancer detection test's potential benefits outweigh its risks and bringing it a step closer to approval.